TICKERNERD
Menu
BIOTBIOTConsumer Defensive · Household & Personal Products

BIOT Stock Forecast: Instinct Bio Technical Co. Holdings, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$0.37
−5.13% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 31 of 100 as at 12 Sept 2026 — in the lower half.

Market cap
$10.7M
Ticker Nerd rank
31 / 100
Median analyst target
—
Analysts covering
—
Total return, dividends reinvested
1W
−7.5%
1M
−11.9%
From high
−97.6%
From low
0.0%
$0
$16
Range since 24 July 2026, adjusted closes · the dot is the last close
Ticker Nerd rank

BIOT stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Instinct Bio Technical Co. Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026
31 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
99
Volatility
89
Accruals
83
Value
43
Issuance
32
Quality
28
Revisions
25
Growth
19
Momentum
11

Size (99): Smaller than most of the companies we track.

Momentum (11): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

BIOT stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on BIOT, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, since 24 July 2026Adjusted close, US dollars
$0$5$10$15Jul 26Aug 26Aug 26Aug 26Aug 26Aug 26Sep 26BIOT

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. BIOT appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

BIOT vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

BIOT vs S&P 500, last 12 monthsTotal return, rebased to 100
020406080100120Jul 26Aug 26Aug 26Aug 26Aug 26Aug 26Sep 26BIOTS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

BIOT analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Instinct Bio Technical Co. Holdings, Inc. (BIOT) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−10.9×

Cheaper than 93% of US stocks

Price / sales
3.9×

Cheaper than 32% of US stocks

Price / book
4.8×

Cheaper than 21% of US stocks

EV / EBITDA
28.3×

Cheaper than 9% of US stocks

Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
—
Operating margin
4.7%

Higher than 54% of US stocks

Net margin
72.4%

Higher than 98% of US stocks

Returns & dividend
Return on equity
3.2%

Higher than 50% of US stocks

Return on assets
2.4%

Higher than 61% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Instinct Bio Technical Co. Holdings, Inc. (BIOT) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Instinct Bio Technical Co. Holdings, Inc. has a market value of $10.7M and an enterprise value of $10.4M.

  • Shares outstanding: 28.8M.

  • Trailing P/E: −10.9×.

  • Instinct Bio Technical Co. Holdings, Inc. employs 0 people.

Statement figures: company filings via Twelve Data, four quarters to 31 Mar 2026 · market figures as at 13 Sept 2026

Data provided by Twelve Data

Peers

BIOT vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHousehold & Personal Products
CompanyMarket capTKN rank
BIOTInstinct Bio Technical Co. Holdings, Inc.$10.7M
31
BYAHPark Ha Biological Technology Co. Ltd.$5.6M
24
TANHTantech Holdings Ltd.$13.7M
16
ATTTAtlas Trinity Tech Ltd.$17.4M
9
DSYBig Tree Cloud Holdings Ltd.$31.1M
4
EDVAEndovia Health Sciences, Inc.*$1.6M
3
UGUnited-Guardian, Inc.$32.9M
91

* Nearest Consumer Defensive names by size — few household & personal products companies of this scale trade in the US universe.

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Instinct Bio Technical Co. Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest BIOT news & analysis

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

GlobeNewsWire · 4 Sept 2026neutral

INSTINCT BIO issued an operational update covering its Indonesia growth platform and product development initiatives. The announcement, released from New York and Tokyo, provides an update on the company's expanding operations.

Why it matters — BIOT watchers will want to track progress on the company's Indonesia expansion and development pipeline, which relate to its stated growth strategy.

Instinct Bio Announces Strategic Collaboration with PT PARVA CANDELA to Develop Cosmetics Business in Indonesia

GlobeNewsWire · 10 Aug 2026positive

Instinct Bio announced a cooperation agreement with PT PARVA CANDELA, an Indonesian cosmetics manufacturer and distributor, to jointly develop Indonesia's cosmetics and personal care market under a "Made in Indonesia, Powered by Japanese Formulation Expertise" concept. The announcement was made from New York and Tokyo on August 10, 2026.

Why it matters — BIOT watchers would care because this partnership marks the company's entry into the Indonesian cosmetics market alongside an established local manufacturer and distributor.

BIOT to Launch Indonesia's First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia's Fastest-Growing Aesthetics Markets

GlobeNewsWire · 29 July 2026positive

BIOT announced it will launch Indonesia's first subscription-model beauty clinics under its own Japanese brand "GENRÊVER CLINIC," aiming to create a recurring-revenue platform in the aesthetics market.

Why it matters — The move represents a strategic push into recurring-revenue streams in a fast-growing Asian market, which could diversify BIOT's business model beyond one-time service sales.

FAQ

Frequently asked questions about BIOT stock

How does Ticker Nerd's model rank BIOT?

As at 12 Sept 2026, Instinct Bio Technical Co. Holdings, Inc. ranks 31 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (99 of 100).

What is the BIOT stock forecast for 2030?

No analyst covering Instinct Bio Technical Co. Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for BIOT are extrapolating price history, which says nothing about the business.

What does Instinct Bio Technical Co. Holdings, Inc. do?

Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution.

What is the latest news on BIOT?

The most recent item we track (GlobeNewsWire, 4 Sept 2026): "INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives". INSTINCT BIO issued an operational update covering its Indonesia growth platform and product development initiatives. The announcement, released from New York and Tokyo, provides an update on the company's expanding operations.

Company

About Instinct Bio Technical Co. Holdings, Inc.

Instinct Bio Technical Company Holdings Inc. focuses on stem cell and regenerative medicine-related products, wellness, and beauty encompassing from research and development, manufacturing, branding, and distribution. It has a strategic collaboration with PT Parva Candela to develop cosmetics business in Indonesia. The company was founded in 2011 and is headquartered in Tokyo, Japan.

CEO Mr. Tomoki Nagano · Japan · https://instinct-biot.com